The week in industry: First cell-based flu vaccine now available in Europe
This week: EMA publishes a revised version of its guidelines for worldwide development of new antibiotics, clinical trial for HIV prevention treatment exceeds expectations and now hopes to increase the number of participants, and the EMA publishes draft guidance on antibiotic development.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>